Thirty-one patients with small cell bronchogenic carcinoma were treated with a regimen of cyclophosphamide, Adriamycin and vincristine. Padiotherapy was given to patients with limited disease. Nonspecific immunotherapy consisting of BCG scarification was administered after each chemotherapy course.
Growth rates of small cell bronchogenic carcinomas
โ Scribed by Brian A. Brigham; Paul A. Bunn Jr.; John D. Minna; Martin H. Cohen; Daniel C. Ihde; Stanley E. Shackney
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 929 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Six patients with bronchogenic carcinomas presenting as solitary nodules had from seven to nine serial chest roentgenograms which permitted measurement of tumor diameters in the absence of definitive therapy. Growth curves were plotted simultaneously on semilogarithmic and arithmetic coordinates to
The benefits of polychemotherapy in advanced (Stage 111) non-small-cell bronchogenic carcinoma remain uncertain. In attempt to answer the important question whether treatment improves well-being and survival in these patients, we did a prospective, randomized, single-blind study to compare polychemo